CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
dose-range finding study in adults with moderate to severe asthma to confirm the dosing regimen of WIN378 that can be tested in future pivot...
Phase 2
Pittsburgh, Pennsylvania, United States and 72 other locations
This is a study to determine the safety, pharmacodynamics (PD), and pharmacokinetics (PK) of CDX-622 in adults with mild to moderate asthma....
Phase 1
Pittsburgh, Pennsylvania, United States and 3 other locations
immunogenicity of APG777 in adult participants with mild-to-moderate asthma.The duration of the study will be approximately 52 weeks (364 da...
Phase 1
Pittsburgh, Pennsylvania, United States and 12 other locations
This study is trying to find the right dose of a long-lasting medicine called GSK5784283 for people with asthma that remains uncontrolled ev...
Phase 2
Pittsburgh, Pennsylvania, United States and 137 other locations
Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) Over a 12-Week Treatment Period in Patients With Severe Asthma...
Phase 2
Pittsburgh, Pennsylvania, United States and 14 other locations
trifenatate (FF/UMEC/VI) with inhaled corticosteroids/long-acting beta-2 agonists (ICS/LABA) in adult participants with uncontrolled asthma...
Phase 4
Pittsburgh, Pennsylvania, United States and 116 other locations
medicine (called tilrekimig) for the potential treatment of severe asthma. Asthma is a condition that makes it challenging to breat...
Phase 3
Pittsburgh, Pennsylvania, United States and 2 other locations
This study is researching a drug called dupilumab. The study is focused on patients who have uncontrolled asthma. Asthma is a condi...
Phase 4
Pittsburgh, Pennsylvania, United States and 77 other locations
levels compared with placebo in participants with moderate-to-severe asthma.Study participation will last approximately 65 weeks, including ...
Phase 2
Pittsburgh, Pennsylvania, United States and 117 other locations
This Phase 2b study is designed to evaluate the safety and efficacy of KT-621 in participants with uncontrolled moderate to severe eosinophilic asthma...
Phase 2
Pittsburgh, Pennsylvania, United States and 80 other locations
Clinical trials
Research sites
Resources
Legal